Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates

Lev Ostrer, Rachel F. Khodursky, James R Johnson, Hiroshi Hiasa, Arkady B Khodursky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fluoroquinolone (FQ)-resistant bacteria pose a major global health threat. Unanalysed genomic data from thousands of sequenced microbes likely contain important hints regarding the evolution of FQ resistance, yet this information lies fallow. Here we analysed the co-occurrence patterns of quinolone resistance mutations in genes encoding the FQ drug targets DNA gyrase (gyrase) and topoisomerase IV (topo-IV) from 36,402 bacterial genomes, representing 10 Gram-positive and 10 Gram-negative species. For 19 species, the likeliest routes toward resistance mutations in both targets were determined, and for 5 species those mutations necessary and sufficient to predict FQ resistance were also determined. Target mutation hierarchy was fixed in all examined Gram-negative species, with gyrase being the primary and topo-IV the secondary quinolone target, as well as in six of nine Gram-positive species, with topo-IV being the primary and gyrase the secondary target. By contrast, in three Gram-positive species (Staphylococcus haemolyticus, Streptococcus pneumoniae and Streptococcus suis), under some conditions gyrase became the primary and topo-IV the secondary target. The path through individual resistance mutations varied by species. Both linear and branched paths were identified in Gram-positive and Gram-negative organisms alike. Finally, FQ resistance could be predicted based solely on target gene quinolone resistance mutations for Acinetobacter baumannii, Escherichia coli and Staphylococcus aureus, but not Klebsiella pneumoniae or Pseudomonas aeruginosa. These findings have important implications both for sequence-based diagnostics and for understanding the emergence of FQ resistance.

Original languageEnglish (US)
Pages (from-to)318-324
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume53
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Quinolones
Fluoroquinolones
DNA Topoisomerase IV
Mutation
Staphylococcus haemolyticus
Streptococcus suis
DNA Gyrase
Bacterial Genomes
Acinetobacter baumannii
Klebsiella pneumoniae
Streptococcus pneumoniae
Pseudomonas aeruginosa
Genes
Staphylococcus aureus
Escherichia coli
Bacteria
Pharmaceutical Preparations

Keywords

  • Bacteria
  • Fluoroquinolones
  • QRDR
  • Quinolone resistance-determining region
  • Resistance
  • Topoisomerases

PubMed: MeSH publication types

  • Journal Article

Cite this

@article{0b6108ff6a324d709414a1e24f4c9025,
title = "Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates",
abstract = "Fluoroquinolone (FQ)-resistant bacteria pose a major global health threat. Unanalysed genomic data from thousands of sequenced microbes likely contain important hints regarding the evolution of FQ resistance, yet this information lies fallow. Here we analysed the co-occurrence patterns of quinolone resistance mutations in genes encoding the FQ drug targets DNA gyrase (gyrase) and topoisomerase IV (topo-IV) from 36,402 bacterial genomes, representing 10 Gram-positive and 10 Gram-negative species. For 19 species, the likeliest routes toward resistance mutations in both targets were determined, and for 5 species those mutations necessary and sufficient to predict FQ resistance were also determined. Target mutation hierarchy was fixed in all examined Gram-negative species, with gyrase being the primary and topo-IV the secondary quinolone target, as well as in six of nine Gram-positive species, with topo-IV being the primary and gyrase the secondary target. By contrast, in three Gram-positive species (Staphylococcus haemolyticus, Streptococcus pneumoniae and Streptococcus suis), under some conditions gyrase became the primary and topo-IV the secondary target. The path through individual resistance mutations varied by species. Both linear and branched paths were identified in Gram-positive and Gram-negative organisms alike. Finally, FQ resistance could be predicted based solely on target gene quinolone resistance mutations for Acinetobacter baumannii, Escherichia coli and Staphylococcus aureus, but not Klebsiella pneumoniae or Pseudomonas aeruginosa. These findings have important implications both for sequence-based diagnostics and for understanding the emergence of FQ resistance.",
keywords = "Bacteria, Fluoroquinolones, QRDR, Quinolone resistance-determining region, Resistance, Topoisomerases",
author = "Lev Ostrer and Khodursky, {Rachel F.} and Johnson, {James R} and Hiroshi Hiasa and Khodursky, {Arkady B}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.ijantimicag.2018.12.004",
language = "English (US)",
volume = "53",
pages = "318--324",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates

AU - Ostrer, Lev

AU - Khodursky, Rachel F.

AU - Johnson, James R

AU - Hiasa, Hiroshi

AU - Khodursky, Arkady B

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Fluoroquinolone (FQ)-resistant bacteria pose a major global health threat. Unanalysed genomic data from thousands of sequenced microbes likely contain important hints regarding the evolution of FQ resistance, yet this information lies fallow. Here we analysed the co-occurrence patterns of quinolone resistance mutations in genes encoding the FQ drug targets DNA gyrase (gyrase) and topoisomerase IV (topo-IV) from 36,402 bacterial genomes, representing 10 Gram-positive and 10 Gram-negative species. For 19 species, the likeliest routes toward resistance mutations in both targets were determined, and for 5 species those mutations necessary and sufficient to predict FQ resistance were also determined. Target mutation hierarchy was fixed in all examined Gram-negative species, with gyrase being the primary and topo-IV the secondary quinolone target, as well as in six of nine Gram-positive species, with topo-IV being the primary and gyrase the secondary target. By contrast, in three Gram-positive species (Staphylococcus haemolyticus, Streptococcus pneumoniae and Streptococcus suis), under some conditions gyrase became the primary and topo-IV the secondary target. The path through individual resistance mutations varied by species. Both linear and branched paths were identified in Gram-positive and Gram-negative organisms alike. Finally, FQ resistance could be predicted based solely on target gene quinolone resistance mutations for Acinetobacter baumannii, Escherichia coli and Staphylococcus aureus, but not Klebsiella pneumoniae or Pseudomonas aeruginosa. These findings have important implications both for sequence-based diagnostics and for understanding the emergence of FQ resistance.

AB - Fluoroquinolone (FQ)-resistant bacteria pose a major global health threat. Unanalysed genomic data from thousands of sequenced microbes likely contain important hints regarding the evolution of FQ resistance, yet this information lies fallow. Here we analysed the co-occurrence patterns of quinolone resistance mutations in genes encoding the FQ drug targets DNA gyrase (gyrase) and topoisomerase IV (topo-IV) from 36,402 bacterial genomes, representing 10 Gram-positive and 10 Gram-negative species. For 19 species, the likeliest routes toward resistance mutations in both targets were determined, and for 5 species those mutations necessary and sufficient to predict FQ resistance were also determined. Target mutation hierarchy was fixed in all examined Gram-negative species, with gyrase being the primary and topo-IV the secondary quinolone target, as well as in six of nine Gram-positive species, with topo-IV being the primary and gyrase the secondary target. By contrast, in three Gram-positive species (Staphylococcus haemolyticus, Streptococcus pneumoniae and Streptococcus suis), under some conditions gyrase became the primary and topo-IV the secondary target. The path through individual resistance mutations varied by species. Both linear and branched paths were identified in Gram-positive and Gram-negative organisms alike. Finally, FQ resistance could be predicted based solely on target gene quinolone resistance mutations for Acinetobacter baumannii, Escherichia coli and Staphylococcus aureus, but not Klebsiella pneumoniae or Pseudomonas aeruginosa. These findings have important implications both for sequence-based diagnostics and for understanding the emergence of FQ resistance.

KW - Bacteria

KW - Fluoroquinolones

KW - QRDR

KW - Quinolone resistance-determining region

KW - Resistance

KW - Topoisomerases

UR - http://www.scopus.com/inward/record.url?scp=85060906330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060906330&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2018.12.004

DO - 10.1016/j.ijantimicag.2018.12.004

M3 - Article

VL - 53

SP - 318

EP - 324

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 3

ER -